AstraZeneca’s no good very bad week

The tech industry may not be the voting bloc that will matter most come November, but the grassroots group Tech4Kamala is hoping to drown out the billionaire executives backing former President Donald Trump with a groundswell of support from entrepreneurs and workers. On POLITICO ...  Show more

Political campaigns are increasingly powered by artificial intelligence, using the technology for behind-the-scenes tasks like writing fundraising emails or social media posts. And in tight races, the best technology (used the right way) can make a big difference. That idea motiv ...  Show more

Vaccination steps up, Trump’s legal shenanigans, Paul Dacre to OFCOM, Myanmar, Navalny and the fallout from the EU’s terrible decision on vaccine exports. Yasmeen Serhan of The Atlantic tells Andrew Harrison what to watch out for in the coming week.“Myanmar will reveal whether th ...  Show more

An AstraZeneca vaccine trial on children gets put on pause while a possible link with rare blood clots is investigated. And former Bank of England governor, Mark Carney, talks climate change, fintech and... should Adam sell his Bitcoin? Today’s Newscast was made by Sam Bonham wit ...  Show more

<span style="color: rgb(0, 0, 0); background-color: transparent;">Senior politics reporter Aaron Blake talks with The Washington Post’s chief correspondent covering national politics, Dan Balz, and national security reporter Abigail Hauslohner about </span><a href="https://www ...